The $450 Patent Mistake: How Novo Nordisk Lost Canadian Semaglutide Market to Generics
The Generics Mindset: Patent Destroyers in Action In the pharmaceutical world, the divide between innovative drug discovery and generic manufacturing…
The Generics Mindset: Patent Destroyers in Action In the pharmaceutical world, the divide between innovative drug discovery and generic manufacturing…
A comprehensive analysis reveals America’s deep dependence on China for pharmaceutical raw materials, with nearly 700 medications using chemicals exclusively sourced from Chinese suppliers. Experts warn this reliance could jeopardize patient access to essential medicines during trade disputes or global health crises.
America’s drug supply chain faces significant vulnerability due to heavy reliance on Chinese-produced raw materials, according to a new analysis from U.S. Pharmacopeia. The report indicates that nearly 700 medications approved for use in the United States depend on chemical substances exclusively manufactured in China, raising concerns about supply stability amid escalating geopolitical tensions.